Profil
Orlando Oliveira is currently Director at Oncoinvent ASA since 2024.
Mr. Oliveira is also Chief Commercial Officer at Zenas BioPharma, Inc. starting in 2024.
Former positions include Director at Oncoinvent ASA (Old), VP-Europe & International Operations at Cubist Pharmaceuticals LLC from 2014 to 2015, Senior Vice President & GM-International at Tesaro, Inc. from 2015 to 2019, Senior Vice President & GM-International at Agios Pharmaceuticals, Inc. from 2019 to 2021, and Senior Vice President & Head-International at Mirati Therapeutics, Inc. from 2022 to 2024.
Education includes an undergraduate degree from the University of Coimbra in 2000, graduate degrees from ISCTE-Instituto Universitário de Lisboa, and the University of Coimbra.
Aktiva positioner av Orlando Oliveira
| Företag | Position | Start |
|---|---|---|
| ONCOINVENT ASA | Direktör/Styrelseledamot | 2024-01-01 |
Tidigare kända positioner av Orlando Oliveira
| Företag | Position | Slut |
|---|---|---|
| MIRATI THERAPEUTICS | Företagsledare/Principal | 2024-04-01 |
| AGIOS PHARMACEUTICALS, INC. | Företagsledare/Principal | 2021-01-01 |
| TESARO INC | Företagsledare/Principal | 2019-06-01 |
| CUBIST PHARMACEUTICALS INC | Företagsledare/Principal | 2015-04-01 |
Oncoinvent AS
Oncoinvent AS Pharmaceuticals: MajorHealth Technology Develops alpha-emitting radiopharmaceuticals for cancer treatment | Direktör/Styrelseledamot | - |
Orlando Oliveiras utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 8 |
|---|---|
Cubist Pharmaceuticals LLC
Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in research, development and commercialization of pharmaceutical products | Health Technology |
Agios Pharmaceuticals, Inc.
Agios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics | Health Technology |
Tesaro, Inc.
Tesaro, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for cancer patients | Health Technology |
Mirati Therapeutics, Inc.
Mirati Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops cancer therapies | Health Technology |
ISCTE-Instituto Universitário de Lisboa
ISCTE-Instituto Universitário de Lisboa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Coimbra
University of Coimbra Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BerGenBio ASA
BerGenBio ASA Pharmaceuticals: MajorHealth Technology Develops drugs for aggressive, drug resistant cancers | Health Technology |
Oncoinvent AS
Oncoinvent AS Pharmaceuticals: MajorHealth Technology Develops alpha-emitting radiopharmaceuticals for cancer treatment | Health Technology |
















